Broadwood Capital Inc
Source: SEC Form 13F · as of Mar 2026Broadwood Capital Inc holds 2 biotech & pharma companies tracked by BioSniper, totaling $117.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
2
Total value held
$117.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Lineage Cell Therapeutics, Inc. (LCTX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| LCTXLineage Cell Therapeutics, Inc. | 49,560,992 | $78.3M |
| IMDXInsight Molecular Diagnostics Inc. | 11,931,839 | $39.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.